Veracyte | VCYT - Market Capitalization

Stock Price
38.48
Daily Change
-0.42 -1.08%
Monthly
16.50%
Yearly
31.78%
Q2 Forecast
37.71

Veracyte reported $3.05B in Market Capitalization this May of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agenus USD 107M 16M Dec/2025
Agilent USD 37.86B 3.64B Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.7B 920M May/2026
Bruker USD 6.41B 915M May/2026
Heron Therapeutics USD 238M 7M Dec/2025
Illumina USD 17.88B 2.74B Mar/2026
Karyopharm Therapeutics USD 956M 821M May/2026
Laboratory Of America USD 21.93B 1.13B Mar/2026
Ligand Pharmaceuticals USD 3.72B 257M May/2026
Myriad Genetics USD 575M 98M Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 217.31B 56.45B May/2026
Sonic Healthcare AUD 11.17B 1.7B Dec/2025
Thermo Fisher Scientific USD 182.66B 35.04B Mar/2026
Veracyte USD 2.59B 16M May/2026
Waters USD 21.02B 8.84B May/2026